Official UK procurement notice
Provision of Managed Pathology Services
Authority: Royal National Orthopaedic Hospital NHS Trust (Central government)
What is being bought
Published requirement descriptionThe Royal National Orthopaedic Hospital NHS Trust (the "Authority") required the Provision of Managed Pathology Services for Royal National Orthopaedic Hospital NHS Trust.<br/><br/>The Authority has awarded the contract in accordance with The Health Care Services (Provider Selection Regime) Regulations 2023 (“PSR 2023”).
CPV: Health services · Pathology services
The lotProcurement structure
single lot · no lot value publishedLot #1The Royal National Orthopaedic Hospital NHS Trust (the "Authority") issued an…AwardedRenewal
The Royal National Orthopaedic Hospital NHS Trust (the "Authority") issued an Invitation to Tender ("ITT") in connection with the competitive procurement for the Provision of Managed Pathology Services for Royal National Orthopaedic Hospital NHS Trust.<br/><br/>The Authority elected to undergo a competitive process conducted in accordance with The Health Care Services (Provider Selection Regime) Regulations 2023 (“PSR 2023”).<br/><br/>In procuring these services, the Authority has acted transparently, fairly and proportionately with a view to securing the needs of the people who use the services, improving the quality of the services, and improving efficiency in the provision of the services transparently, fairly and proportionately.<br/><br/>The Authority requires a single supplier to provide services for an on-site pathology laboratory with access to further tests to be completed offsite, along with timely clinical advice in a number of specialities. The required service is for an end-to-end outsourced pathology service. The Authority was not seeking an equipment provider. The Authority is outsourcing pathology services to a third-party laboratory who will run and manage the services on site at RNOH.<br/><br/>The service is required 24 hours a day, 365 days a year.<br/><br/>The contract term will be for an eight (8) year period with the option to extend for two (2) years and then a further one (1) year commending on 1st November 2025. <br/><br/>A service mobilisation period is applicable from 1st May 2025. The appointed supplier will align with the Trust's EPR deployment timeline, which requires the Supplier's current pathology configuration and Test environment to be available by 15th November 2024 and connected to our Trust integration engine.
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- No (one-off requirement)
- First published
- 2 Sept 2024, 14:39 BST
- Last source update
- 28 Nov 2024, 11:09 GMT
- Award evaluation window
- 2 Sept 2024 – …
- Authority reference
C297003- FTS notice number
2024/S 000-038413- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-049743Find a Tender
- Why no open competition
- The procurement falls outside the scope of application of the directive
- Published justification
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the standstill period. Representations by providers must be made to decision makers by 5th November 2024. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
How it was run
Official noticeTender documents are also served through a separate tool: https://health-family.force.com/s/Welcome ↗
- Submission deadline
- 30 Sept 2024, 12:00 BST
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bid validity
- 180 days from the deadline
- Bids opened
- 2 Sept 2024, 17:00 BST
Timeline
2 Sept 2024 → 28 Nov 2024 · 3 dates- Bids opened2 Sept 2024, 17:00 BST
- Submission deadline30 Sept 2024, 12:00 BST
- Notice published28 Nov 2024, 11:09 GMT
Notice history
2 events · 3 releases on Find a Tender · since 24 Oct 2024- Status changed to complete24 Oct 2024, 18:08 BST
- Procurement method changed24 Oct 2024, 18:08 BST
Published amendments (1)
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This contract has now been formally awarded using a competitive process.The contract term will be f…
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| HSL Pathology LLPSME | £20,222,523 † | — | Awarded |
Contracts
Contract 034577-2024-1 · HSL Pathology LLPSME
- Signed
- 24 Oct 2024
- Value
- £20,222,523
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 3bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Independent Choice and Procurement Panel.Review body
- The High CourtMediation bodyReview body
Bidders & participating suppliers
1 commercial party on the notice- HSL PATHOLOGY LLPAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.